Hemophagocytic lymphohistiocytosis (HLH) is a rare and often fatal disease if not diagnosed and treated promptly. HLH can be due to genetic factors or infections, malignancies and collagen-associated vascular diseases. Malignancy-associated HLH is not only more common in the setting of T/NK-cell lymphomas, but may also rarely be seen in the setting of B-cell lymphoma. Here, we describe a unique case of a patient who initially was diagnosed with HLH secondary to Epstein Barr virus (EBV) infection and subsequently developed EBV-positive diffuse large B-cell lymphoma affecting the brain. This case highlights the spectrum of findings associated with EBV infections and the challenges in diagnosing underlying diseases associated with HLH.
CITATION STYLE
Ricard, J. A., Charles, R., Tommee, C. G., Yohe, S., Robert Bell, W., & Flanagan, M. E. (2020). Epstein virus Barr-positive diffuse large B-Cell lymphoma associated with hemophagocytic lymphohistiocytosis. Journal of Neuropathology and Experimental Neurology, 79(8), 915–920. https://doi.org/10.1093/jnen/nlaa061
Mendeley helps you to discover research relevant for your work.